Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Cancer Chemotherapy Reports
|
October 1, 1972
5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma
E Frei, J K Luce, R W Talley, et al.
JAMA
|
August 13, 1973
Excessive lacrimation from fluorouracil treatment
J Hamersley, J K Luce, T R Florentz, et al.
Cancer
|
October 1, 1973
Intra-arterial infusion therapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC 45388) for malignant melanoma
L H Einhorn, C M McBride, J K Luce, et al.
Cancer Treatment Reports
|
September 1, 1977
Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group
C A Coltman, J K Luce, E M McKelvey, et al.
Archives of Internal Medicine
|
March 1, 1973
Chemotherapy of Hodgkin's disease. Maintenance therapy vs no maintenance after remission induction with combination chemotherapy
J K Luce, E Frei, E A Gehan, et al.
Cancer
|
July 1, 1973
Phase II evaluation of adriamycin in human neoplasia
R M O'Bryan, J K Luce, R W Talley, et al.
Cancer
|
January 1, 1977
Combination chemotherapy with bis chloroethyl nitrosourea (BCNU), vincristine and dimethyl triazeno imidazole carboxamide (DTIC) in disseminated malignant melanoma
E M McKelvey, J K Luce, R W Talley, et al.
Cancer
|
January 1, 1977
Bis chloroethyl nitrosourea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanoma
E M McKelvey, J K Luce, V K Vaitkevicius, et al.
Cancer
|
July 1, 1976
Phase II evaluation of bleomycin. A Southwest oncology Group study
C D Haas, C A Coltman, J A Gottlieb, et al.
Cancer
|
December 1, 1972
Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide
J A Gottlieb, L H Baker, J M Quagliana, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Cancer Chemotherapy Reports
|
October 1, 1972
5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma
E Frei, J K Luce, R W Talley, et al.
JAMA
|
August 13, 1973
Excessive lacrimation from fluorouracil treatment
J Hamersley, J K Luce, T R Florentz, et al.
Cancer
|
October 1, 1973
Intra-arterial infusion therapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC 45388) for malignant melanoma
L H Einhorn, C M McBride, J K Luce, et al.
Cancer Treatment Reports
|
September 1, 1977
Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group
C A Coltman, J K Luce, E M McKelvey, et al.
Archives of Internal Medicine
|
March 1, 1973
Chemotherapy of Hodgkin's disease. Maintenance therapy vs no maintenance after remission induction with combination chemotherapy
J K Luce, E Frei, E A Gehan, et al.
Cancer
|
July 1, 1973
Phase II evaluation of adriamycin in human neoplasia
R M O'Bryan, J K Luce, R W Talley, et al.
Cancer
|
January 1, 1977
Combination chemotherapy with bis chloroethyl nitrosourea (BCNU), vincristine and dimethyl triazeno imidazole carboxamide (DTIC) in disseminated malignant melanoma
E M McKelvey, J K Luce, R W Talley, et al.
Cancer
|
January 1, 1977
Bis chloroethyl nitrosourea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanoma
E M McKelvey, J K Luce, V K Vaitkevicius, et al.
Cancer
|
July 1, 1976
Phase II evaluation of bleomycin. A Southwest oncology Group study
C D Haas, C A Coltman, J A Gottlieb, et al.
Cancer
|
December 1, 1972
Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide
J A Gottlieb, L H Baker, J M Quagliana, et al.
Page
of 5